James Wooldridge

Insider Reports History

Entity
Individual
Location
C/O Checkmate Pharmaceuticals, Inc., 245 Main Street, 2 Nd Floor, Cambridge, MA
Signature
/s/ Kleem Chaudhary, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Wooldridge:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Checkmate Pharmaceuticals, Inc. Chief Medical Officer Stock Option (Right to Buy) 0 May 31, 2022 Direct

Insider Reports Filed by James Wooldridge

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CMPI Checkmate Pharmaceuticals, Inc. May 31, 2022 5 $0 4 May 31, 2022 Chief Medical Officer
CMPI Checkmate Pharmaceuticals, Inc. Jan 27, 2022 1 $0 4 Jan 31, 2022 Chief Medical Officer
CMPI Checkmate Pharmaceuticals, Inc. Aug 4, 2021 1 $0 4 Aug 6, 2021 Chief Medical Officer
CMPI Checkmate Pharmaceuticals, Inc. Mar 4, 2021 1 $0 4 Apr 28, 2022 Chief Medical Officer